Androgen deprivation therapy for prostate cancer: long-term safety and patient outcomes
Hamed Ahmadi, Siamak Daneshmand Institute of Urology, University of Southern California, Los Angeles, CA, USA Abstract: Androgen deprivation therapy (ADT) constitutes the first-line treatment for patients with locally advanced tumors, recurrent or metastatic disease. Given its widespread use, clin...
| Main Authors: | , , |
|---|---|
| Format: | Article |
| Language: | English |
| Published: |
Dove Medical Press
2014-07-01
|
| Series: | Patient Related Outcome Measures |
| Online Access: | http://www.dovepress.com/androgen-deprivation-therapy-for-prostate-cancer-long-term-safety-and--a17476 |